Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PEARL-DM: Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD; Randomized Controlled Trial From Pakistan.

NCT05942963 is registered in ClinicalTrials.gov with Jinnah Postgraduate Medical Centre as lead sponsor.

NCT NCT05942963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05942963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PEARL-DM: Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD; Randomized Controlled Trial From Pakistan.
Lead sponsor
Jinnah Postgraduate Medical Centre
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2023
Completion date
April 30, 2024
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver disease, type2diabetes